CONTEXT: More than half the male population aged> 50 yr have histologic evidence of
benign prostatic hyperplasia (BPH), while prostate cancer (PCa) is among the most common …

Benign prostatic hyperplasia (BPH) and prostate cancer are among the most common
diseases of the prostate gland and represent significant burdens for patients and health-care …

BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a
precursor for prostate carcinoma. However, because the two conditions share not only a …

CONTEXT: Benign prostatic hyperplasia (BPH) is a well-known condition characterised by
prostate growth accompanied by lower urinary tract symptoms. Several mechanisms seem …

BACKGROUND: Although benign prostate hyperplasia (BPH) and prostate cancer (PCa)
share features such as hormone-dependent growth and response to treatment with …

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer... : Medicine Benign Prostatic
Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of …

Benign prostatic hyperplasia (BPH) can be found in 88% of autopsies in men≥ 80 years,
with compatible symptomatology reported in nearly 50% of men aged≥ 50 years in the …

Background: Benign prostatic hyperplasia (BPH) is often associated with enlargement of the
prostate gland, lower urinary tract symptoms, decreased urinary flow and a reduced quality …

This study examined the association between symptomatic benign prostatic hyperplasia
(BPH) and prostate cancer risk in 5,068 placebo-arm participants enrolled in the Prostate …

Objectives To present historical and contemporary hypotheses on the pathogenesis of
benign prostatic hyperplasia (BPH), and the potential implications for current medical …